Halley E. Gilbert's most recent trade in CytomX Therapeutics Inc was a trade of 59,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CytomX Therapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 59,000 | 59,000 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 11,389 | 11,389 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 2,265 | 12,481 | - | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 5,778 | 27,901 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Sale of securities on an exchange or to another person at price $ 27.55 per share. | 20 Nov 2025 | 16,532 | 22,123 (0%) | 0% | 27.5 | 455,442 | Common Stock |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 20 Nov 2025 | 12,220 | 38,655 (0%) | 0% | 7.5 | 91,772 | Common Stock |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,220 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 20,568 | 20,568 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,372 | 15,372 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 7,609 | 26,435 (0%) | 0% | 0 | Common Stock | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 3,041 | 10,216 | - | 0 | Common Stock | |
| CytomX Therapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 10,139 | 18,826 (0%) | 0% | 0 | Common Stock | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,250 | 7,250 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,550 | 7,175 | - | 0 | Common Stock | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Sale of securities on an exchange or to another person at price $ 73.00 per share. | 03 Jun 2024 | 18,200 | 5,625 | - | 73 | 1,328,600 | Common Stock |
| Vaxcyte Inc | Halley E. Gilbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 03 Jun 2024 | 18,200 | 23,825 | - | 5.4 | 97,370 | Common Stock |
| Vaxcyte Inc | Halley E. Gilbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 18,200 | 30,374 | - | - | Stock Option (Right to Buy) | |
| CytomX Therapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| CytomX Therapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 2,500 | 5,625 | - | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 12,220 | 12,220 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 4,375 | 8,687 (0%) | 0% | 0 | Common Stock | |
| CytomX Therapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,796 | 11,796 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 4,312 | 4,312 (0%) | 0% | 0 | Common Stock | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,125 | 3,125 | - | 0 | Common Stock | |
| Neogenomics Inc | Halley E. Gilbert | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 102,623 | 102,623 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc | Halley E. Gilbert | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 42,036 | 147,396 (0%) | 0% | 0 | Common Stock |